Article Information
History
- August 8, 2021.
Article Versions
- Version 1 (March 26, 2021 - 12:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alexander O. Pasternak1,*,
- Jelmer Vroom1,
- Neeltje A. Kootstra2,
- Ferdinand W.N.M. Wit3,4,5,6,
- Marijn de Bruin7,8,
- Davide De Francesco9,
- Margreet Bakker1,
- Caroline A Sabin9,
- Alan Winston10,
- Jan M. Prins6,
- Peter Reiss3,4,5,
- Ben Berkhout1 and
- on behalf of The Co-morBidity in Relation to Aids (COBRA) Collaboration
- 1Amsterdam UMC, University of Amsterdam, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands
- 2Amsterdam UMC, University of Amsterdam, Laboratory of Viral Immune Pathogenesis, Department of Experimental Immunology, Amsterdam, The Netherlands
- 3Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
- 4Amsterdam UMC, University of Amsterdam, Department of Global Health, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands
- 5HIV Monitoring Foundation, Amsterdam, The Netherlands
- 6Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Amsterdam, The Netherlands
- 7Health Psychology Group, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom
- 8Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands
- 9Institute for Global Health, University College London, London, United Kingdom
- 10Department of Medicine, Imperial College London, London, United Kingdom.
- ↵*Corresponding author. Email: a.o.pasternak{at}amsterdamumc.nl